Kolexia
Tournilhac Olivier Hématologie
Tournilhac Olivier
Hématologie
Hôpital Estaing
Clermont-Ferrand, France
369 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Leucémies Leucémie chronique lymphocytaire à cellules B Leucémie lymphoïde Macroglobulinémie de Waldenström Lymphome T Lymphome B Lymphome T périphérique Lymphome B diffus à grandes cellules

Collaborateurs

Voir plus
Leblond Véronique
Leblond Véronique
Hôpital Pitie Salpetriere, Paris, France
Feugier Pierre
Feugier Pierre
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Guieze Romain
Guieze Romain
Hôpital Estaing, Clermont-Ferrand, France
Ysebaert Loic
Ysebaert Loic
Oncopole Toulouse, Toulouse, France

Industries

Voir plus
Takeda Pharmaceutical
34 collaboration(s)
Dernière en 2023
P\S\L Group Services
27 collaboration(s)
Dernière en 2023
IQVIA
10 collaboration(s)
Dernière en 2022
Abbvie
8 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
LyMa101: Phase II Study to Evaluate the Efficacy of Upfront Obinutuzumab in Mantle Cell Lymphoma Patients Treated by DHAP Followed by Autologous Transplantation Plus Obinutuzumab Maintenance Then MRD Driven Maintenance
Essai Clinique (The Lymphoma Academic Research Organisation)   13 mars 2024
Faster clinical decisions in B-cell acute lymphoblastic leukaemia: A single flow cytometric 12-colour tube improves diagnosis and minimal residual disease follow-up.
British journal of haematology   03 mars 2024
An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia
Essai Clinique (Acerta Pharma BV)   18 janvier 2024
Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Haematologica   11 janvier 2024
R2-CHOP2: A Phase Ib/II Study of Escalating Doses of Revlimid in Association With R-CHOP (R2-CHOP) in the Treatment of B-cell Lymphoma
Essai Clinique (The Lymphoma Academic Research Organisation)   04 décembre 2023
Study of Lacutamab in Peripheral T-cell Lymphoma: A Randomized Non Comparative Phase II Study of Lacutamab With GemOx Versus GemOx Alone in Relapsed/Refractory Patients With Peripheral T-cell Lymphoma
Essai Clinique (Innate Pharma)   04 décembre 2023
Leucémie myélomonocytaire chronique et hypokaliémie inexpliquée : chercher du lysozyme dans le tubule !
87e CONGRÈS FRANÇAIS DE MÉDECINE INTERNE   01 décembre 2023
Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia: Efficacy of First Line Dexamethasone, Rituximab and Cyclophosphamide (DRC) +/- Bortezomib for Patients With Waldenström's Macroglobulinemia
Essai Clinique (University of Ulm)   29 novembre 2023
Retrospective multicenter comparative study of the efficacy and safety between R-DHAC and R-DHAOx in diffuse large B-cell lymphoma or transformed follicular or marginal zone B lymphoma into aggressive lymphoma, as a second-line treatment.
Leukemia & lymphoma   15 novembre 2023
Minimal Residual Disease-Guided Combination of Ibrutinib and Venetoclax Compared to FCR in Untreated Patients with CLL of Intermediate Risk : Interim Results of MRD Kinetics in the Eradic Trial from the Filo Group
65th ASH Annual Meeting Abstracts   02 novembre 2023